Varenicline In-Patient Study

Phase 2 Completed 17 enrolled Stanford University Pfizer · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This Investigator Initiated Research Award (IIR Award #WS981308) is a two-part pilot study that aims to examine acceptability and feasibility of varenicline use during an acute (72-hr) smoke-free hospitalization (Part 1) and 4-weeks post-hospitalization (Part 2).

Timeline

Start: 2011-08
Primary completion: 2014-10
Completion: 2014-10

Publications

Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Varenicline	Small molecule	0.5 mg	—

Indications

No indication recorded.